Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|April 26, 2005
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)David L Paterson, Flávia Rossi, Fernando Baquero, et al.
Clinical and Vaccine Immunology : CVI|July 28, 2012
Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysisMoustafa Moustafa, George R Aronoff, Chandra Chandran, et al.
The Journal of Infectious Diseases|March 28, 2003
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapyAlfred J Saah, David W Haas, Mark J DiNubile, et al.
Plos One|March 22, 2018
Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trialFleur P Paling, Karina Olsen, Kristin Ohneberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe OutcomesWesley H Self, Richard G Wunderink, Mark J DiNubile, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2015
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvirRong Liu, Stephanie Curry, Patricia McMonagle, et al.
Vaccine|April 20, 2006
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infantsTimo Vesikari, H Fred Clark, Paul A Offit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2013
Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosisMaribel Rodriguez-Torres, Albrecht Stoehr, Edward J Gane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infectionAnita Y M Howe, Stuart Black, Stephanie Curry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Pageof 10